- Home
- GALT vs TKNO Comparison
GALT vs TKNO Comparison
Compare GALT & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GALT
- TKNO
- Stock Information
- Founded
- GALT 2000
- TKNO 1996
- Country
- GALT United States
- TKNO United States
- Employees
- GALT N/A
- TKNO N/A
- Industry
- GALT Biotechnology: Pharmaceutical Preparations
- TKNO Medicinal Chemicals and Botanical Products
- Sector
- GALT Health Care
- TKNO Health Care
- Exchange
- GALT Nasdaq
- TKNO Nasdaq
- Market Cap
- GALT 86.0M
- TKNO 356.4M
- IPO Year
- GALT N/A
- TKNO 2021
- Fundamental
- Price
- GALT $1.36
- TKNO $7.08
- Analyst Decision
- GALT Hold
- TKNO Buy
- Analyst Count
- GALT 1
- TKNO 1
- Target Price
- GALT N/A
- TKNO $5.00
- AVG Volume (30 Days)
- GALT 177.8K
- TKNO 406.2K
- Earning Date
- GALT 05-19-2025
- TKNO 05-08-2025
- Dividend Yield
- GALT N/A
- TKNO N/A
- EPS Growth
- GALT N/A
- TKNO N/A
- EPS
- GALT N/A
- TKNO N/A
- Revenue
- GALT N/A
- TKNO $37,745,000.00
- Revenue This Year
- GALT N/A
- TKNO $9.58
- Revenue Next Year
- GALT N/A
- TKNO $15.97
- P/E Ratio
- GALT N/A
- TKNO N/A
- Revenue Growth
- GALT N/A
- TKNO 2.89
- 52 Week Low
- GALT $0.73
- TKNO $1.16
- 52 Week High
- GALT $3.41
- TKNO $10.37
- Technical
- Relative Strength Index (RSI)
- GALT 49.34
- TKNO 55.17
- Support Level
- GALT $1.26
- TKNO $5.70
- Resistance Level
- GALT $1.63
- TKNO $6.85
- Average True Range (ATR)
- GALT 0.12
- TKNO 0.48
- MACD
- GALT 0.02
- TKNO -0.01
- Stochastic Oscillator
- GALT 35.00
- TKNO 65.64
About GALT Galectin Therapeutics Inc.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.
About TKNO Alpha Teknova Inc.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.